Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W. De Backer
A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Expression of Bronchodilator Response Using Forced Oscillation Technique Measurements: Absolute Versus Relative
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Related publications
Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma
Pulmonary Pharmacology and Therapeutics
Biochemistry
Medicine
Pulmonary
Respiratory Medicine
Pharmacology
Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma
Respiratory Research
Pulmonary
Respiratory Medicine
Once-Daily Fluticasone Furoate/Vilanterol Combination Versus Twice-Daily Budesonide/Formoterol Combination in the Treatment of Controlled Stable Asthma: A Randomized Crossover Trial
Journal of Asthma and Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Integrated Safety and Efficacy Analysis of Once-Daily Fluticasone Furoate for the Treatment of Asthma
Respiratory Research
Pulmonary
Respiratory Medicine
Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study
Thorax
Pulmonary
Respiratory Medicine
Single-Inhaler Triple Therapy Utilizing the Once-Daily Combination of Fluticasone Furoate, Umeclidinium and Vilanterol in the Management of COPD: The Current Evidence Base and Future Prospects
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Austri, a Large Randomized Study in Adolescents and Adults With Asthma, Assessing the Safety and Efficacy of Salmeterol in Combination With Fluticasone Propionate Compared to Fluticasone Propionate Alone
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial
Respiratory Medicine
Pulmonary
Respiratory Medicine